The signing up of the pharmacies is so important at the moment as it is the initial land grab. The revenue is inconsequential at the moment as they are building an empire. Calculating current revenues is pointless with this stock as the strategy is signing as many pharmacies as possible at the moment. Once they have a complete monopoly of the market then the revenues will matter because they can charge higher premiums.
This is dirt cheap for what is on offer imo
Ann: Quarterly Activities Report and Appendix 4C - June 16-MDR.AX, page-11
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
